Загрузка...
Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer
Stage I colorectal carcinoma has excellent prognosis, with 5-year survival rate up to 95%. The occurrence of lymphovascular invasion, tumor budding, high number of PDC, or lymph node micrometastases is associated with tumor progression. The aim of this study was to evaluate the mutational status of...
Сохранить в:
| Опубликовано в: : | Dis Markers |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6029483/ https://ncbi.nlm.nih.gov/pubmed/30018674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/2959801 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|